Survey: Halting neurodegeneration chief concern in Huntington’s disease

According to results of a recent survey, more than 80% of U.S.-based neurologists agreed that a major unmet need in confronting Huntington’s disease is halting neurodegeneration prior to the onset of symptoms.
Furthermore, an equal number of professionals in the specialty expressed frustration with the absence of meaningful treatments to slow cognitive decline.
Spherix Global Insights conducted a market landscape study to gather insights from neurologists responsible for treatment of the condition. Due to a broad range of symptoms affecting motor function, cognitive abilities and

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart